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Abstract
 
Although T cell receptor (TCR) signals are essential for intrathymic T cell–positive selection, it
remains controversial whether they only serve to initiate this process, or whether they are re-
quired throughout to promote thymocyte differentiation and survival. To address this issue, we
have devised a novel approach to interfere with thymocyte TCR signaling in a developmental
stage-specific manner in vivo. We have reconstituted mice deficient for Zap70, a tyrosine ki-
nase required for TCR signaling and normally expressed throughout T cell development, with
a Zap70 transgene driven by the adenosine deaminase (ADA) gene enhancer, which is active in
CD4
 
 
 
CD8
 
 
 
 thymocytes but inactive in CD4
 
 
 
 or CD8
 
 
 
 single-positive (SP) thymocytes. In
such mice, termination of Zap70 expression impaired TCR signal transduction and arrested
thymocyte development after the initiation, but before the completion, of positive selection.
Arrested thymocytes had terminated Rag gene expression and up-regulated TCR and Bcl-2
expression, but failed to differentiate into mature CD4 or CD8 SP thymocytes, to be rescued
from death by neglect or to sustain interleukin 7R
 
 
 
 expression. These observations identify a
TCR-dependent proofreading mechanism that verifies thymocyte TCR specificity and differ-
entiation choices before the completion of positive selection.
 
Key words: T cell development • thymus • antigen receptor rearrangement • transgenic mice • 
adenosine deaminase
 
Introduction
 
The differentiation of CD4
 
 
 
CD8
 
 
 
 double-positive (DP)
 
*
 
thymocytes into CD4
 
 
 
CD8
 
 
 
 or CD4
 
 
 
CD8
 
 
 
 single-posi-
tive (SP) thymocytes is a critical step during 
 
  
 
 T cell in-
trathymic development (1). DP thymocytes are short-lived
cells that have successively rearranged their TCR
 
 
 
 genes,
actively rearrange their TCR
 
 
 
 genes, and express surface
TCR
 
  
 
 complexes upon productive TCR
 
 
 
 rearrange-
ment. Current models of T cell development propose that
the fate of DP thymocytes is dictated by their TCR avidity
for self-MHC peptide complexes (MHC-p) expressed on
the thymic stroma (2–4), so that only those DP thymocytes
whose TCR binds self MHC-p with intermediate avidity
differentiate into mature T cells, a process referred to as
positive selection which requires intracellular TCR signal-
ing (5, 6).
Thymocytes undergoing positive selection are subject
to multiple developmental changes, including the cessa-
tion of Rag-1 and Rag-2 recombinase gene expression
(7, 8), which terminates TCR
 
 
 
 gene rearrangement and
fixes TCR specificity, the up-regulation of Bcl-2 and of
surface TCR expression (4, 9, 10), the termination of
CD8 or CD4 expression (3, 4), and the acquisition of the
IL-7–dependent survival pattern that characterizes mature
T cells (11–15). While TCR signaling is required for
these differentiation events, how TCR signals promote
them remains unclear. As these differentiation events occur
sequentially rather than simultaneously, it can be envi-
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*
 
Abbreviations used in this paper:
 
 ADA, adenosine deaminase; DP, dou-
ble positive; MFI, mean fluorescence intensity; MHC-p, MHC-peptide
complex; SP, single positive.T
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sioned that TCR signals only serve at the onset of the
selection process, to initiate in DP thymocytes a develop-
mental sequence which then progresses in a TCR-inde-
pendent manner. Alternatively, it is possible that persis-
tent or repeated TCR signaling is required throughout
positive selection.
To examine this issue, it is necessary to disrupt TCR en-
gagements or TCR signal transduction in thymocytes after
the initiation, but before the completion, of positive selec-
tion. Achieving this goal directly in vivo has so far re-
mained elusive, and indirect attempts based on adoptive
cell transfer or in vitro signaling strategies have led to con-
flicting conclusions: while some observations suggest that
multiple TCR signaling events are required for positive se-
lection (16, 17), others support the opposite view, namely
that a short-duration TCR signaling episode ‘commits’ DP
thymocytes to a differentiation sequence that is subse-
quently TCR independent (18).
The objective of the present study was to address these
issues in vivo, by limiting the developmental window of
TCR signal transduction in thymocytes. Our approach was
to confine to DP thymocytes the expression of Zap70, a ty-
rosine kinase normally expressed throughout T cell devel-
opment (19, 20). This choice was driven by the fact that
Zap70 gene disruption precludes TCR signal transduction
in DP thymocytes but does not affect their generation:
Zap70
 
 
 
 mice have no SP thymocytes nor mature T cells,
but normal numbers of TCR
 
  
 
-expressing DP thy-
mocytes (5, 6).
Here we reconstituted Zap70
 
 
 
 mice with a Zap70 trans-
gene expressed in DP but not in SP thymocytes, thereby
selectively enabling TCR signal transduction in DP thy-
mocytes. As a result, intrathymically signaled thymocytes
initiated, but failed to complete, positive selection, demon-
strating that positive selection requires repeated or persis-
tent TCR signals beyond the DP stage. However, while
‘DP-restricted’ TCR signals failed to reconstitute positive
selection, they promoted its initial steps, including the fixa-
tion of TCR specificity and the up-regulation of TCR and
Bcl-2 expression. These findings reveal a late proofreading
TCR signaling step during positive selection and provide a
novel approach to dissect this process.
 
Materials and Methods
 
Generation of Transgenic Mice.
 
A cDNA encoding a C-termi-
nally myc-tagged version of mouse Zap70 was generated by oli-
gonucleotide-directed mutagenesis of the murine Zap70 cDNA
(21). The predicted C-terminal amino acid sequence of the re-
sulting protein was as follows (single letter code, a slash separates
Zap70 and myc sequences): vaeaacg/ELASMEQKLISEED-
LNNG. A human adenosine deaminase (ADA)-based transgenic
expression vector was constructed from plasmid pADACAT
4/12 (22) by replacing chloramphenicol acetyl transferase sequences
with the myc-tagged Zap70 cDNA. Detailed cloning procedures
are available on request. The DNA sequence of all oligonucle-
otide-encoded regions was verified by dideoxy sequencing. The
transgene DNA was microinjected in fertilized C57BL/6 (B6)
oocytes as described previously (23). Founder mice were identi-
fied by Southern blotting on tail DNA; transgenic mice were
backcrossed to Zap70
 
 
 
 mice and subsequently identified by PCR
on tail DNA. Both myc-tagged and untagged Zap70 cDNAs
were also inserted into pcDNA3 (Invitrogen) for expression in
P116 cells.
 
Animals.
 
Wild-type (B6) mice were from the National Can-
cer Institute (NCI) animal facility. Zap-70
 
 
 
 mice (5) were ob-
tained from Dr. Alfred Singer (NCI); mice transgenic for the
P14 TCR (24) on an H-2
 
b
 
 background were from The Jackson
Laboratory. Except where otherwise indicated, mice were ana-
lyzed between 5 and 10 wk of age, and were heterozygous for
the transgene(s) they carry. All mice used in this study were
housed and cared for in accordance with National Institutes of
Health guidelines.
 
Antibodies.
 
The following mAbs were used for staining: anti
c-myc (9E10; Santa Cruz Biotechnology, Inc.); anti-TCR
 
 
 
(H57–597), anti-CD4 (RM4.4 and GK1.5), anti-CD8 (53–6.7),
anti-CD69 (H1.2F3), anti-HSA (CD24, M1/69), anti–IL-7R
 
 
 
,
and anti–mouse Bcl-2 (3F11), all from BD Biosciences. The fol-
lowing antibodies were used for immunoprecipitation or immu-
noblotting: anti-phosphotyrosine (4G10; Upstate Biotechnol-
ogy), anti-phospho-Erk (E10) and anti-Erk2 (both from Cell
Signaling Technologies), anti-LAT (25), and anti-Zap70 (both
from Dr. Lawrence Samelson, NCI).
 
Cell Preparation, Staining, and Stimulation.
 
Single cell suspen-
sions of thymocytes, splenocytes, or LN cells were prepared and
surface stained as described previously (10). Splenocytes suspen-
sions were cleared of red blood cells by ACK treatment. Cells
were stained for intracellular transgenic Zap70 (9E10 anti-myc)
or Bcl-2 after 10 min fixation (2% formaldehyde PBS, room tem-
perature) and 5 min permeabilization in IC staining buffer (0.03%
saponin, 0.1% BSA, 0.1% NaN
 
3
 
 PBS). Intracellular staining for
detection of phospho-Erk molecules was performed after 3 min
fixation (8% formaldehyde PBS, room temperature) and perme-
abilization in IC staining buffer. Cell fluorescence was measured,
typically on 10
 
5
 
 cells, on a 2-laser FACSCalibur™ (BD Bio-
sciences) with 4-decade logarithmic amplification, and analyzed
using FlowJo software. Live cells were identified by forward light
scatter and propidium iodide gating, or by forward and side light
scatter gating for 4-color and intracellular staining analyses. Puri-
fied thymocyte populations were prepared using anti-CD4
(GK1.5), anti-CD8 (53–6.7), or anti-FITC coated magnetic
beads (Miltenyi Biotec) as follows: (a) DP thymocytes by selec-
tion of CD4
 
 
 
 cells (P14 TCR transgenic mice), or by selection of
CD8
 
 
 
 cells (all other mice), (b) CD69
 
 
 
 cells by selection of
FITC
 
 
 
 cells after cell surface staining with FITC-conjugated
anti-CD69. Cell purity, assessed by surface staining and flow cy-
tometry, was 
 
 
 
95% except where otherwise indicated. LN T
cells (cell purity 
 
 
 
90%) were B cell depleted using anti–mouse
immunoglobulin magnetic beads (Polysciences). For in vitro
stimulation of DP thymocytes, cells were coated for 10 min at
4
 
 
 
C with biotinylated anti-TCR
 
 
 
 and anti-CD4 (GK1.5), both
from BD Biosciences, cross-linked with streptavidin (Southern
Biotechnology Associates, Inc.), and processed for immunopre-
cipitation and immunoblotting as described (23). P116 cells were
transfected by electroporation, distributed on plates previously
coated with anti-CD3 (UCHT-1; BD Biosciences) at the indi-
cated concentration, and analyzed for CD69 expression after 16 h
at 37
 
 
 
C.
 
RT-PCR.
 
Total RNA was extracted using Trizol (Invitro-
gen) and reverse-transcribed by oligo-dT priming using the
Thermoscript RT-PCR Kit (Invitrogen). Taq-mediated PCR
was performed for 35 cycles using the following parameters forT
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each cycle: 94 
 
 
 
C (45 s), 55 
 
 
 
C (45 s), and 72 
 
 
 
C (2.5 min). PCR
products were separated by agarose gel electrophoresis and
visualized by ethydium bromide staining. PCR primers
were as follows: Rag-1 (GenBank XM_123916) (5
 
 
 
ccaagc-
tgcagacattctagcactc3
 
 
 
 and 5
 
 
 
caacatctgccttcacgtcgatcc3
 
 
 
); Rag-2
(GenBank NM_009020) (5
 
 
 
cacatccacaagcaggaagtacac3
 
 
 
 and
5
 
 
 
ggttcagggacatctcctactaag3
 
 
 
) and 
 
 
 
-actin (GenBank AF054837)
(5
 
 
 
gtgggccgctctaggcacc3
 
 
 
 and 5
 
 
 
ctctttgatgtcacgcacgat3
 
 
 
).
 
Calcium Flux Measurements.
 
Calcium fluxes were measured
following published procedures (26). Briefly, thymocytes were
loaded with 1.8 
 
 
 
M indo-1 AM (Molecular Probes) for 30
 
 
 
min
at 37
 
 
 
C, washed twice, incubated for 30 min at 4
 
 
 
C with bio-
tinylated anti-TCR
 
 
 
, or with anti-TCR
 
 
 
 and anti-CD4 (GK
1.5), and with fluorochrome-conjugated mAb against CD8 and
CD4 (RM4.4, which does not cross react with GK1.5), and fi-
nally washed twice. Cell stimulation (at 37
 
 
 
C) and fluorescence
measurements were performed on a specially equipped FAC-
Star
 
PLUS™
 
 (BD Biosciences). TCR cross-linking was initiated
2 min after transferring cells at 37
 
 
 
C by adding 2 
 
 
 
g/ml strepta-
vidin. Fluorescence was collected over 512 s and analyzed using
FlowJo software.
 
Results
 
A Mouse Line Expressing Zap70 in DP but Not in SP Thy-
mocytes.
 
To confine TCR signaling to DP thymocytes,
we reconstituted Zap70
 
 
 
 mice with a Zap70 transgene
driven by a human ADA DP-specific enhancer, active in
DP thymocytes but not in SP thymocytes or in mature
T cells (22; Fig. 1 A). Transgenic Zap70 molecules were
appended a C-terminal myc epitope tag to facilitate their
detection. Transient transfection analyses in Zap70-defi-
cient P116 Jurkat cells (27) verified that the myc tag did
not impair Zap70 function (Fig. 1 B). Two independent
mouse lines, referred to as A and D2, expressed this
transgene in DP thymocytes with little or no residual
expression in SP thymocytes or mature T cells. As both
lines generated similar phenotypes after backcrossing to
Zap70
 
 
 
 mice, and as transgene expression was 1.5–2 fold
higher in line A than in line D2 thymocytes (unpub-
lished data), we report here analyses made with line A
mice.
We assessed transgene expression by immunoblotting
Zap70 molecules immunoprecipitated from cells heterozy-
gous for endogenous Zap70 and for the ADA-Zap70
transgene (Zap70
 
 
 
/
 
 
 
ADA-Zap70
 
 
 
/
 
 
 
). Transgenic Zap70
molecules, which migrate with reduced electrophoretic
mobility because of the epitope tag, were detected in DP
thymocytes but not in CD4 and CD8 SP thymocytes or in
lymph node T cells (Fig. 1 C); in DP thymocytes, the ratio
of transgenic to endogenous Zap70 molecules was 0.47:1,
as assessed by densitometric scanning and serial dilution
analyses (Fig. 1 C, and unpublished data). As a result,
Zap70 expression in Zap70
 
 
 
 thymocytes homozygous for
the ADA-Zap70 transgene was similar (98 
 
 
 
 13% based on
three distinct experiments) to that in Zap70
 
 
 
/
 
 
 
 thy-
mocytes (Fig. 1 C, lanes 6 and 8). Confirming these results,
analyses of transgene expression by anti–myc-epitope in-
tracellular staining detected transgenic Zap70 in DP thy-
mocytes but not significantly in CD4 or CD8 SP thy-
mocytes (Fig. 1 D). Thus, the ADA-Zap70 transgene is
expressed in DP thymocytes, but not in SP thymocytes or
mature T cells.
Figure 1. Expression of the ADA-Zap70 transgene. (A) Schematic of the
ADA-Zap70 transgene. A C-terminally myc-tagged murine Zap70 cDNA
was inserted between the promoter and the first intron enhancer of the hu-
man ADA gene. Numbered boxes depict the first and second exon of the
ADA gene, pA indicates intronic and polyadenylation sequences from the
polyoma middle T gene and black arrows the transcription start sites. (B)
myc-epitope tagged Zap70 molecules are fully functional. Zap70-deficient
P116 cells were transiently transfected with myc-tagged or untagged Zap70
expression vectors, or with an empty expression vector (mock). Dose–
response curves to TCR stimulation were established by measuring anti-
CD3-induced CD69 expression; for each antibody concentration, CD69
fluorescence is expressed as ([MFI of transfected cells]   [MFI of mock-
transfected cells]) where MFI is the mean fluorescence intensity. (C) The
ADA-Zap70 transgene is expressed in DP thymocytes but not in SP thy-
mocytes and peripheral T cells. (left) Purified DP, CD8SP, and CD4SP
thymocytes, and LN T cells (lanes 1–4) or unseparated ( 85% DP) thy-
mocytes (lanes 5–9), were lysed in 1% Triton X-100 buffer and assessed for
endogenous and transgenic Zap70 by anti-Zap70 immunoprecipitation and
immunoblotting; (right) expression of transgenic Zap70 relative to that of
endogenous Zap70 in each cell population of Zap70 /  mice heterozygous
for the ADA-Zap70 transgene was quantified by autoradiogram scanning of
three distinct experiments. Also note that endogenous Zap70 expression
was 1.4-fold higher in Zap70 /  than in Zap70 /  thymocytes (lanes 5 and
6). (D) Flow cytometric analysis of transgenic Zap70 expression. Thy-
mocytes from wild-type and transgenic mice were stained for surface CD4
and CD8 and for intracellular transgenic Zap70 (9E10 anti-myc), and ana-
lyzed by flow cytometry. Numbers within each box indicate transgenic
Zap70 expression, calculated in each population as: 100   ([MFI of trans-
genic cells]   [MFI of nontransgenic cells])/(MFI of nontransgenic cells).
Results are the mean from three independent experiments. (E) Activity of
Zap70 transgenic Zap70 molecules. Purified DP thymocytes were stimu-
lated for 5 min by anti-TCR   anti-CD4 cocrosslinking, lysed, and
assessed  for LAT tyrosine phosphorylation by immunoblotting of anti-
LAT immunoprecipitates. Equal loading of the lanes was verified by anti-
LAT immunoblotting. The relative stimulation of LAT phosphorylation is
indicated for each mouse genotype.T
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The ADA-Zap70 Transgene Fails to Restore Positive Selec-
tion.
 
We crossed ADA-Zap70 transgenic and Zap70
 
 
 
mice to generate Zap70
 
 
 
 mice heterozygous for the ADA-
Zap70 transgene (Zap70
 
 
 
ADA-Zap70
 
 
 
/
 
 
 
, thereafter re-
ferred to as ADA-ZapA). That the transgenic protein was
active in DP thymocytes was confirmed by its ability to
promote TCR 
 
  
 
CD4-induced tyrosine-phosphorylation
of LAT, a direct substrate of Zap70 (25), in ADA-ZapA DP
thymocytes (Fig. 1 E, lanes 3–6). To examine if the ADA-
Zap70 transgene restored positive selection in the absence
of endogenous Zap70, we assessed thymocyte and T cell
populations in ADA-ZapA mice by surface staining and
flow cytometry. Normally, DP thymocytes undergoing
positive selection up-regulate TCR surface expression as
they differentiate into CD4 or CD8 SP cells, and subse-
quently down-regulate HSA (CD24) surface expression
(28); thus, the number of HSA
 
lo
 
 SP thymocytes is indicative
of the efficiency of positive selection. Importantly, ADA-
ZapA mice had essentially no HSA
 
lo
 
 CD4 or CD8 SP thy-
mocytes, indicating that the transgene failed to restore posi-
tive selection in mice lacking endogenous Zap70 (Fig. 2 A).
Consistent with this conclusion, peripheral T cell popula-
tions were absent in newborn and 2-wk-old ADA-ZapA
mice (unpublished data) and remained marginal in young
adults (Fig. 2 A), possibly arising by peripheral expansion of
infrequent thymus-derived T cells that overcame the
intrathymic differentiation block. However, ADA-ZapA
thymi critically differed from Zap70
 
 
 
 thymi in that some
ADA-ZapA thymocytes were intrathymically signaled to
initiate selection, as evidenced by their TCR
 
hi
 
 DP or transi-
tional (CD4
 
 
 
CD8
 
lo
 
 or CD4loCD8 ) surface phenotype
(Fig. 2 B and Table I). Thus, while the T cell development
block was essentially as complete in ADA-ZapA and
Zap70  mice, the block in ADA-ZapA mice occurred at a
subsequent developmental stage, namely in CD4 CD8lo
and CD4loCD8  thymocytes which are developmental in-
termediates between DP and SP thymocytes (29–31).
Strikingly, the same differentiation block was observed in
Zap70  mice homozygous for the ADA-Zap70 transgene
(ADA-ZapA / ; Fig. 2, A and B), despite the fact that
ADA-ZapA /  DP thymocytes expressed as much Zap70 as
Zap70 /  DP thymocytes which differentiated normally
into SP cells (Fig. 1 C). While both ADA-ZapA and ADA-
ZapA /  thymi had significant, albeit reduced, numbers of
CD4 CD8  thymocytes, these CD4 CD8  cells remained
HSAhi and failed to give rise to normal CD8 T cell popula-
tions. These observations demonstrate that the cessation of
Zap70 expression during the DP to SP transition prevents
the completion of intrathymic T cell differentiation.
The ADA-Zap70 Transgene Enables TCR Signaling in DP
but Not in Transitional Thymocytes. Given the unusual de-
velopmental block exhibited by the ADA-ZapA mouse,
we examined in more detail how the ADA-Zap70 trans-
gene restored TCR signal transduction, by assessing in
ADA-ZapA thymocytes two critical targets of TCR signal-
ing during positive selection (32–34): calcium mobilization,
measured by flow cytometric analysis of calcium-
dependent indo-1 fluorescence, and MAP kinase activa-
Figure 2. Expression of the ADA-Zap70 transgene in Zap70  mice
fails to restore positive selection. Thymocyte and splenocyte suspen-
sions were enumerated by trypan blue exclusion (total cell numbers are
shown as mean   SEM) and assessed by surface staining and flow cy-
tometry for expression of CD4, CD8, and HSA (A, thymocytes) or
CD4, CD8 and TCR  (A, splenocytes; B). Populations were quanti-
fied by multiplying total cell numbers by the fraction of cells in that
population and are shown as mean   SEM. Numbers next to or within
boxes (A and B, two color contour plots) indicate the percentage of
cells in that box. Note that CD4 /loCD8  cells in Zap70  mice were
TCRlo precursors of DP thymocytes which were also present in all
other strains.T
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tion, measured by intracellular staining and by immunoblot
analyses, using a monoclonal antibody which recognizes
dually (threonine/tyrosine) phosphorylated, activated, Erk1
and Erk2 molecules (35).
TCR   CD4-induced calcium mobilization (Fig. 3 A,
top) and Erk phosphorylation (Fig. 3 C, top, and Fig. 3 D,
lanes 3–6) were both disrupted in Zap70  DP thymocytes,
and restored by the ADA-Zap70 transgene. Of note, while
heterozygous expression of the transgene was sufficient to
restore TCR   CD4-induced Erk phosphorylation (Fig. 3
D), calcium mobilization appeared to be more stringently
dependent on Zap70 levels, as TCR   CD4-induced cal-
cium fluxes increased with Zap70 expression (Fig. 3 A,
compare the progression from ADA-ZapA to Zap70 / ).
Unlike in DP thymocytes, TCR   CD4-induced calcium
mobilization and Erk phosphorylation were both markedly
impaired in ADA-ZapA CD4 CD8lo thymocytes relative
to their Zap70  counterparts (Fig. 3, A and C, bottom).
Furthermore, cross-linking of TCR alone, which allowed
simultaneous assessment of CD4 CD8lo and CD4loCD8 
thymocyte responses by providing a coreceptor-indepen-
dent stimulation, induced strong calcium responses in wild-
type CD4 CD8lo and CD4loCD8  populations, but failed
to do so in their ADA-ZapA counterparts (Fig. 3 B). Thus,
as assessed on MAP kinase activation and calcium mobiliza-
tion, the ADA-Zap70 transgene reconstituted Zap70  mice
for TCR signal transduction in DP thymocytes but not in
CD4 CD8lo and CD4loCD8  transitional thymocytes; of
note, these observations demonstrate that TCR signaling
requires Zap70 beyond the DP stage of T cell development
in mice.
Two Genetically Separable Signaling Steps during Positive Se-
lection. We next examined if intrathymically signaled
ADA-ZapA DP thymocytes normally initiated their differ-
entiation. We first documented that normal numbers of
ADA-ZapA DP thymocytes expressed CD69, one of the
earliest marker of positive selection (36, 37), in contrast to
Zap70  DP thymocytes which all were CD69  (Fig. 4 A).
Second, we showed that CD69  ADA-ZapA thymocytes
had been signaled to terminate Rag-1 and Rag-2 gene ex-
pression, a critical event during positive selection (7, 8, 38–
41): Rag-1 and Rag-2 expression was reduced by 10-fold
in intrathymically signaled ADA-ZapA CD69  cells rela-
tive to their CD69  counterpart (Fig. 4 B). Finally, we as-
sessed ADA-ZapA DP thymocytes for expression of antiap-
optotic Bcl-2 molecules and of the IL-7 receptor  -subunit
(IL-7R ), which is necessary to naive T cell survival after
their exit from the thymus (11, 12, 14, 15). Bcl-2 and IL-
7R , which are silent on most DP thymocytes (9, 10, 13),
were up-regulated by TCRhi DP thymocytes in both
Zap70  and ADA-ZapA mice (Fig. 4 C). These observa-
tions indicated that ADA-ZapA DP thymocytes normally
initiated their differentiation.
In contrast, a series of observations indicated that the fur-
ther development of ADA-ZapA transitional thymocytes
was markedly affected by the cessation of Zap70 expres-
sion. First, ADA-ZapA transitional thymocytes failed not
only to progress to the SP stage, but also to accumulate
over time, indicating that they were not rescued from
death by neglect: the total number of ADA-ZapA transi-
tional thymocytes was less than that in age-matched
Zap70  mice, at ages 4 d, 2 wk, and 6–8 wk (Fig. 5 A).
Furthermore, IL-7R  and CD69 levels were lower on
ADA-ZapA than on Zap70  transitional thymocytes, a dif-
ference modest on CD4 CD8lo cells but particularly strik-
ing on CD4loCD8  thymocytes (Fig. 5 B, a). Importantly,
the same was true of ADA-ZapA /  transitional thy-
mocytes and of the small population of TCRhiCD4 CD8 
Table I. TCRhi Transitional Cells Do Not Accumulate with Age in ADA-ZapA Thymi
Cell numbers ( 10 6)a
Age Genotype TCRhi DP TCRhiCD4 CD8lo TCRhiCD4loCD8 
4 d Zap70 /  0.19   0.01 0.08   0.01 0.05   0.003
ADA-ZapA 0.17   0.005 0.02   0.005 0.07   0.004
Zap70   0.01  0.001  0.001
2 wk Zap70 /  0.98   0.11 0.51   0.05 0.11   0.01
ADA-ZapA 0.8 0.28 0.17
Zap70   0.01  0.01  0.01
6–8 wk Zap70 /  5.1   0.48 3.8   0.57 1.0   0.16
ADA-ZapA 6.2   0.74 1.9   0.17 2.0   0.33
Zap70  0.23   0.04 0.03   0.005 0.04   0.001
aThymocytes were triple stained for CD4, CD8, and TCR  surface expression. Cell numbers were calculated as in the legend to Fig. 2 and are in-
dicated as mean   SEM. At least two mice of each genotype were analyzed for each time point, with the exception of 2-wk-old mice, in which two
Zap70 /  and one ADA-ZapA mice were analyzed. T
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thymocytes present in ADA-ZapA /  mice (Fig. 5 B, b,
and unpublished data). Of note, Bcl-2 levels remained high
in ADA-ZapA transitional thymocytes (Fig. 5 B), perhaps
because cells with insufficient Bcl-2 expression were rap-
idly eliminated from the thymus by programmed cell
death. Altogether, these observations demonstrate that the
cessation of TCR signaling in transitional thymocytes dis-
rupted the completion of thymocyte differentiation.
Figure 3. TCR signal transduction operates in DP but not in transitional ADA-ZapA thymocytes. (A and
B) Calcium flux measurements. Unseparated thymocytes were loaded with indo-1, surface stained for CD4
and CD8, and coated with biotinylated anti-TCR  and anti-CD4 (A) or with biotinylated anti-TCR  only
(B). Calcium fluxes (median of Indo-1 405/Indo-1 510 fluorescence ratio, vertical axes) were recorded be-
fore and after signaling was induced by addition of streptavidin at t   120 s (arrow) and are shown for gated
DP and CD4 CD8lo populations (A) or DP, CD4 CD8lo and CD4 /loCD8  populations (B). (C and D)
Analyses of MAP kinase activation. In C, unseparated thymocytes were stimulated by anti-TCR   anti-
CD4 streptavidin-mediated cocrosslinking, fixed, stained for surface CD4 and CD8 and intracellular phos-
pho-Erk (using the E10 mAb), and analyzed by flow cytometry; phospho-Erk staining is shown on gated DP
and CD4 CD8lo populations. In D, purified CD8  thymocytes ( 95% DP) were stimulated by anti-TCR  
anti-CD4 cocrosslinking, lysed, and assessed for Erk phosphorylation by immunoblotting of whole cell ly-
sates with the anti-phospho-Erk E10 mAb. Equal lane loading was verified by anti-Erk2 immunoblotting.
The relative stimulation of Erk phosphorylation is indicated for each mouse genotype. An asterisk indicates a
non specific band on the anti-phospho-Erk blot.
Figure 4. Intrathymic TCR signaling promotes the differentiation of ADA-ZapA DP
thymocytes. (A) Thymocytes were stained for CD4, CD8, and CD69. CD69 levels on
gated DP thymocytes are shown as single-color histograms for each mouse genotype. (B)
Intrathymically signaled (CD69 ) ADA-ZapA thymocytes down-regulate Rag gene ex-
pression. CD69  and unsignaled CD69  ADA-ZapA thymocytes were separated with mag-
netic beads. The CD69  population was 85% CD69  (of which 80% were CD4 CD8 ,
and 20% CD4 CD8lo or CD4loCD8 ) and 15% CD69 /lo (all CD4 CD8 ; not shown).
RT-PCR analysis showed a 10-fold decreased Rag-1 and Rag-2 gene expression in
CD69  (bottom) compared with CD69  (top) cells, corresponding to the degree of purity
of the CD69  population. For each cDNA preparation, PCRs were performed from 300,
100, 30, and 10 cell equivalents (left to right).  -actin expression, assessed in parallel as a
control for cDNA preparation, was identical in both populations. (C) Zap70 /  and ADA-
ZapA thymocytes were stained for surface TCR , CD4, and CD8, and for intracellular
Bcl-2 (top) or for surface IL-7R , TCR , CD4, and CD8 (bottom). Surface IL-7R  and
intracellular Bcl-2 levels on gated TCRhi DP thymocytes are shown as single color histo-
grams, and were identical in ADA-ZapA and Zap70 /  cells. For comparison, shaded histo-
grams show Bcl-2 (top) or IL-7R  (bottom) levels on TCR lo Zap70 /  DP thymocytes.T
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Finally, to verify that MHC-p ligands that normally pro-
mote positive selection initiate the differentiation of ADA-
ZapA thymocytes, we generated ADA-ZapA mice in
which all thymocytes express the MHC I–restricted P14
TCR transgene, which promotes positive selection of CD8
T cells in Zap70  H-2Db mice (24). Unlike Zap70  thy-
mocytes expressing the P14 transgene, ADA-ZapA thy-
mocytes expressing the P14 transgene (ADA-ZapA/P14)
failed to differentiate into CD8 SP cells (Fig. 6 A). How-
ever, ADA-ZapA/P14 thymocytes had initiated positive
selection, as indicated (a) by their elevated CD69 and re-
duced Rag-1 and Rag-2 expression relative to their Zap70 
counterparts (Fig. 6 A, right and 6 B), and (b) by the fact
that they differentiated into CD4loCD8  thymocytes ex-
pressing high levels of the transgenic V  2 chain (Fig. 6
C). We conclude from these observations that TCR/
MHC-p interactions that normally promote positive selec-
tion in Zap70  mice cause ADA-ZapA thymocytes to ini-
tiate positive selection. Unexpectedly, CD8 SP and
CD4loCD8  thymocytes from P14 transgenic Zap70  mice
only had marginal surface IL-7R  expression (unpublished
Figure 5. ADA-ZapA transitional thymocytes fail to differentiate. (A)
Transitional thymocytes do not accumulate with age in ADA-ZapA
thymi. Total numbers of both TCRhiCD4 CD8lo and TCRhi
CD4loCD8  transitional thymocytes were calculated (from data shown in
Table I) in ADA-ZapA and Zap70 /  mice aged 4 d, 2 wk, and 6–8 wk.
Numbers of transitional thymocytes in ADA-ZapA mice (white bars) are
expressed relative to those in their aged-matched Zap70 /  counterparts
(set to 1 for each age group, black bars). (B) Transitional thymocytes fail
to sustain CD69 and IL-7R  expression in the absence of TCR signals.
(a) Zap70 /  and ADA-ZapA thymocytes were stained as in Fig. 4 C.
CD69, IL-7R , and intracellular Bcl-2 levels on gated TCRhi CD4 
CD8lo (top) or CD4loCD8  (bottom) thymocytes are shown as single
color histograms. Expression of both CD69 and IL-7R , but not of Bcl-2,
was lower in ADA-ZapA than in Zap70 /  cells. (b) IL-7R  expression
was assessed as in the legend to Fig. 4 C on TCRhi transitional and
CD4 CD8  thymocytes from ADA-ZapA (plain lines, left) and ADA-
ZapA /  (plain lines, right) mice and compared with that on their
Zap70 /  counterparts (dashed lines). For comparison, shaded histograms
in panels a and b show CD69, IL-7R , or intracellular Bcl-2 levels on
Zap70  DP thymocytes.
Figure 6. ADA-ZapA DP thymocytes initiate positive selection in re-
sponse to normally positively selecting MHC-p. (A)  Single cell thy-
mocyte suspensions were prepared from mice of the indicated genotypes,
all expressing the P14 TCR transgene. Thymocytes were assessed for
CD4, CD8, and CD69 expression by 3-color flow cytometry. Left,
2-color contour plots show the absence of mature CD8SP cells in ADA-
ZapA/P14 mice. Right, single parameter analyses of CD69 expression
show up-regulated CD69 expression in P14-transgenic Zap70 /  and
ADA-ZapA DP thymocytes (black lines), but not in Zap70  thymocytes
(filled gray histograms). Note the previously described reduced thymic
cellularity in TCR transgenic Zap70  mice (reference 42). One represen-
tative experiment is shown out of three. (B) Rag-1 and Rag-2 gene ex-
pression was analyzed on purified CD4  thymocytes ( 95% DP) from
the indicated mice. PCRs were performed from 300, 100, 30, and 10
cell-equivalents. (C) Thymocytes were assessed for CD4, CD8, TCR ,
and V -2 expression by 4-color flow cytometry. Single-color histograms
show V -2 expression on CD4loCD8  populations. A bracket indicates
the V -2hi  population; all such V -2hi thymocytes were TCR hi,
whereas most V -2-/lo thymocytes were TCR lo, and thus presumably
pre-DP thymocytes.T
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data), preventing us from using this parameter to assess the
differentiation status of CD4loCD8  cells from ADA-
ZapA/P14 mice.
Discussion
In this study, our objective was to examine if thymocytes
that have been TCR-signaled to initiate positive selection
complete their development in a TCR-independent man-
ner. To this end, we restricted the developmental window
of TCR signaling by generating a novel mouse model in
which Zap70 expression, hence TCR signal transduction,
is confined to DP thymocytes. Using this approach, we
show that thymocyte differentiation requires TCR signals
throughout positive selection, that is, that thymocytes
proofread their TCR specificity and differentiation choices
before completing their intrathymic development.
Stage-specific Zap70 Expression as a New Model to Study
Positive Selection. In the present study, we constructed a
Zap70 transgene driven by a human ADA enhancer active
in cortical (DP) but not medullary (SP) thymocytes (22),
and showed that this transgene reconstitutes Zap70  mice
for both Zap70 expression and TCR signal transduction in
DP, but not in CD4 CD8lo and CD4loCD8 , thymocytes.
Unlike the ADA-Zap70 transgene, Zap70 transgenes
driven by the Lck promoter had previously been reported
to restore positive selection in Zap70  mice (5, 42). We
think this difference is explained by the fact that the Lck
proximal promoter is active in SP thymocytes (43), unlike
the ADA enhancer used in the present study.
Importantly, the ADA-Zap70 transgene restored the ini-
tial steps of positive selection by all phenotypic criteria we
assessed, including the termination of Rag expression and
the up-regulation of CD5 (unpublished data), CD69,
TCR, and Bcl-2; thus, ADA-ZapA and ADA-ZapA / 
thymocytes fail to differentiate into mature T cells not be-
cause they did not properly initiate positive selection, but
because they become signaling-defective after they initiate
positive selection and fail to generate late TCR signals re-
quired to complete their differentiation.
Persistent or Repeated TCR Signaling Proofreads Differentia-
tion Decisions during Positive Selection. Our observations
show that thymocyte survival and differentiation remain
dependent on TCR signals after the fixation of TCR spec-
ificity, and the up-regulation of surface TCR and Bcl-2
expression, and thus demonstrate the existence of a late
TCR signaling step that proofreads thymocyte differentia-
tion choices during positive selection. The existence of a
late ‘rescue’ or proofreading TCR signaling step required
for the completion of positive selection has long remained
controversial. That positive selection requires multiple
TCR signaling steps was first suggested by the facts that it
extends over several days in vivo (44) and cannot be repro-
duced by short-duration TCR engagements in vitro (45).
However, assessment of this idea by adoptive cell transfer
experiments gave rise to conflicting results. A study fo-
cused on positive selection by the HY transgenic TCR
found that the development of HY transgenic T cells re-
quired selecting MHC molecules throughout positive se-
lection (16). In contrast, a more extensive analysis of sev-
eral TCR-transgenic and non–TCR-transgenic models
reached the opposite conclusion, namely that intrathymi-
cally signaled (CD69 ) DP thymocytes need no additional
MHC-p/TCR engagements to differentiate into SP cells
(18). Finally, contradictory conclusions also emerged from
recent studies in which DP thymocytes were signaled in
vitro using pharmacological agents (46) or antigen-present-
ing cells (17).
The genetic strategy used in the present study clarifies
these contradictions as it bypasses limitations inherent to
indirect approaches. First, unlike adoptive cell transfers, the
genetic strategy interrupts TCR signaling without disrupt-
ing MHC/TCR engagements and other potentially impor-
tant thymocyte–stroma interactions (47). Another limita-
tion of cell transfer approaches is that they necessarily rely
on the assumption that the adoptively transferred ‘signaled’
(CD69  or TCRhi) DP thymocytes are precursors of SP
thymocytes; in fact, while CD69 or TCR up-regulation
precedes CD4 or CD8 SP thymocyte differentiation (36,
37), precursor–progeny relationships between ‘signaled’
(CD69hi or TCRhi) DP thymocytes and mature SP thy-
mocytes remain debated (30, 31, 48). Finally, our genetic
strategy ensures that thymocytes are TCR signaled by thy-
mic epithelial cells, rather than by pharmacological agents,
antibody-mediated TCR cross-linking, or by dendritic
cells which, unlike thymic epithelial cells, express costimu-
latory molecules previously shown to promote thymocyte
death (17, 49).
A Genetic Dissection of Positive Selection. Our approach
reveals two genetically separable signaling steps during pos-
itive selection that serve, the first one to engage DP thy-
mocytes into the selection process, and the second one to
promote IL-7R  up-regulation and rescue from death by
neglect in transitional and SP thymocytes. Importantly,
neither cell transfer nor gene targeted disruption ap-
proaches had so far succeeded in dissociating differentiation
events during positive selection. In fact, the developmental
block in ADA-ZapA mice is unique as (a) it is complete,
unlike the partial blocks in Vav- or Erk1-deficient mice, or
in mice expressing a ‘dominant negative’ version of Lck, all
of which allow reduced numbers of DP cells to initiate se-
lection and to differentiate into mature T cells (34, 50–54)
and (b) as it occurs after the initiation of positive selection,
unlike the block at an ‘unsignaled’ DP stage in Zap70  thy-
mocytes (5, 6). Of note, our observations are consistent
with the idea that TCR signaling thresholds increase dur-
ing the terminal maturation of SP thymocytes (55–57) and
do not exclude the existence of subsequent, TCR-inde-
pendent, maturation stages during the terminal differentia-
tion of CD4 or CD8 SP thymocytes (58).
That TCR signals are required for transitional thy-
mocytes to sustain IL-7R  expression has important bio-
logical consequences. Although IL-7 function during posi-
tive selection remains controversial (59, 60), the critical
role of IL-7 for T cell survival makes IL-7R  up-regula-
tion an essential event during SP thymocyte differentiationT
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(12–15). We propose that the TCR-dependence of IL-
7R  expression during positive selection is an important
proofreading mechanism that ensures that only thymocytes
with appropriate TCR specificity and matching coreceptor
expression will be allowed to durably participate in the pe-
ripheral T cell repertoire.
Whether, and how, CD4/CD8 lineage choice occurs in
ADA-ZapA mice was not directly addressed by the present
study. The presence in ADA-ZapA mice of a CD4 /lo
CD8  population, which normally includes CD8 cell pre-
cursors (30, 31), indicates that the cessation of transgenic
Zap70 expression did not preclude CD8 lineage choice; in
contrast, the presence of a CD4 CD8lo population is not
informative with regard to lineage choice, as this popula-
tion normally includes cells on their way to become CD4
or CD8 SP thymocytes (30, 31). We and others have pro-
posed that the duration of TCR signals during positive se-
lection determines CD4/CD8 lineage choice, with persis-
tent signals promoting CD4 lineage choice and transient
signals promoting CD8 lineage choice (60–62); future ex-
periments will use ADA-ZapA mice to address this issue.
Finally, it is interesting to relate the proofreading mecha-
nism revealed by the present study to observations suggest-
ing that DP thymocytes sequentially rearrange their TCR 
loci, and thus eliminate previously rearranged TCR  genes
(63, 64). As termination of Rag gene expression is not im-
mediate in cells undergoing positive selection (7, 39), these
observations raised the possibility, illustrated in mice carry-
ing a TCR  transgene and a rearranged TCR  allele
‘knocked-in’ the endogenous TCR  locus (65, 66), that a
selecting TCR  chain might be deleted by subsequent
TCR  rearrangement. The present study now indicates
that thymocytes that eliminate selecting TCR  specificities
after initiating positive selection, thereby discontinuing ex-
pression of selecting TCR   complexes, would fail to de-
velop as mature T cells.
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